Hepatocellular carcinoma immune landscape and the potential of immunotherapies

J Giraud, D Chalopin, JF Blanc, M Saleh - Frontiers in immunology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is the most common liver tumor and among the deadliest
cancers worldwide. Advanced HCC overall survival is meager and has not improved over …

Metabolic programs tailor T cell immunity in viral infection, cancer, and aging

SH Møller, PC Hsueh, YR Yu, L Zhang, PC Ho - Cell metabolism, 2022 - cell.com
Productive T cell responses to infection and cancer rely on coordinated metabolic
reprogramming and epigenetic remodeling among the immune cells. In particular, T cell …

Treatment selection in first-line metastatic renal cell carcinoma—the contemporary treatment paradigm in the age of combination therapy: a review

V Navani, DYC Heng - JAMA oncology, 2022 - jamanetwork.com
Importance The treatment landscape of metastatic renal cell carcinoma has evolved rapidly
over the last decade. Recent combination approaches heralded by targeting immune …

Induction of immortal-like and functional CAR T cells by defined factors

L Wang, G Jin, Q Zhou, Y Liu, X Zhao, Z Li… - Journal of Experimental …, 2024 - rupress.org
Long-term antitumor efficacy of chimeric antigen receptor (CAR) T cells depends on their
functional persistence in vivo. T cells with stem-like properties show better persistence, but …

Role of the tumor immune microenvironment in tumor immunotherapy

C Zhou, Q Liu, Y Xiang, X Gou, W Li - Oncology Letters, 2022 - spandidos-publications.com
Tumor immunotherapy is considered to be a novel and promising therapy for tumors and it
has recently become a hot research topic. The clinical success of tumor immunotherapy has …

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications

X Chi, S Luo, P Ye, WL Hwang, JH Cha, X Yan… - Frontiers in …, 2023 - frontiersin.org
T cells play a crucial role in the regulation of immune response and are integral to the
efficacy of cancer immunotherapy. Because immunotherapy has emerged as a promising …

Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells

Z Zhang, M Langenbach, S Sagar, V Fetsch… - Nature …, 2024 - nature.com
The mechanisms underlying the efficacy of anti-programmed cell death protein 1 (PD-1) and
anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) therapy are incompletely …

Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion

JW Polania, A Hoyt-Miggelbrink, WH Tomaszewski… - Immunity, 2024 - cell.com
Whereas terminally exhausted T (Tex_term) cells retain anti-tumor cytotoxic functions, the
frequencies of stem-like progenitor-exhausted T (Tex_prog) cells better reflect …

TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses

R Harris, M Mammadli, S Hiner, L Suo, Q Yang… - Cancer Immunology …, 2023 - Springer
Cancer immunotherapy relies on improving T cell effector functions against malignancies,
but despite the identification of several key transcription factors (TFs), the biological …

Normal aging induces PD-1-enriched exhausted microglia and A1-like reactive astrocytes in the hypothalamus

Y Suda, T Nakashima, H Matsumoto, D Sato… - Biochemical and …, 2021 - Elsevier
Hypothalamic aging is considered to be critical for systemic aging, and the accumulation of
“exhausted glial cells” in the hypothalamus may contribute to brain dysfunction. In this study …